Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.
Roberts MJ, Conduit C, Davis ID, Effeney RM, Williams S, Martin JM, Hofman MS, Hruby G, Eapen R, Gianacas C, Papa N, Lourenço RA, Dhillon HM, Allen R, Fontela A, Kaur B, Emmett L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Roberts MJ, et al. Among authors: eapen r. BJU Int. 2024 Feb;133 Suppl 3:39-47. doi: 10.1111/bju.16158. Epub 2023 Sep 14. BJU Int. 2024. PMID: 37604702
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy.
Dhiantravan N, Violet J, Eapen R, Alghazo O, Scalzo M, Jackson P, Keam SP, Mitchell C, Neeson PJ, Sandhu S, Williams SG, Moon D, Lawrentschuk N, Azad A, Hofman MS, Murphy DG. Dhiantravan N, et al. Among authors: eapen r. Eur Urol Focus. 2021 Mar;7(2):234-237. doi: 10.1016/j.euf.2020.09.021. Epub 2020 Nov 7. Eur Urol Focus. 2021. PMID: 33172774
Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer.
O'Brien JS, McVey A, Kelly BD, Jenjitranant P, Buteau J, Hofman MS, Kasivisvanithan V, Eapen R, Moon D, Murphy DG, Lawrentschuk N. O'Brien JS, et al. Among authors: eapen r. BJU Int. 2022 Nov;130 Suppl 3:8-10. doi: 10.1111/bju.15773. Epub 2022 Jul 12. BJU Int. 2022. PMID: 35574991 No abstract available.
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma.
Udovicich C, Callahan J, Bressel M, Ong WL, Perera M, Tran B, Azad A, Haran S, Moon D, Chander S, Shaw M, Eapen R, Goad J, Lawrentschuk N, Murphy DG, Hofman M, Siva S. Udovicich C, et al. Among authors: eapen r. Eur Urol Open Sci. 2022 Aug 29;44:60-68. doi: 10.1016/j.euros.2022.08.001. eCollection 2022 Oct. Eur Urol Open Sci. 2022. PMID: 36185587 Free PMC article.
Role of FDG PET/CT in Management of Patients with Prostate Cancer.
Sutherland DEK, Azad AA, Murphy DG, Eapen RS, Kostos L, Hofman MS. Sutherland DEK, et al. Among authors: eapen rs. Semin Nucl Med. 2024 Jan;54(1):4-13. doi: 10.1053/j.semnuclmed.2023.06.005. Epub 2023 Jul 1. Semin Nucl Med. 2024. PMID: 37400321 Review.
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.
Eapen RS, Buteau JP, Jackson P, Mitchell C, Oon SF, Alghazo O, McIntosh L, Dhiantravan N, Scalzo MJ, O'Brien J, Sandhu S, Azad AA, Williams SG, Sharma G, Haskali MB, Bressel M, Chen K, Jenjitranant P, McVey A, Moon D, Lawrentschuk N, Neeson PJ, Murphy DG, Hofman MS. Eapen RS, et al. Eur Urol. 2024 Mar;85(3):217-226. doi: 10.1016/j.eururo.2023.08.026. Epub 2023 Oct 26. Eur Urol. 2024. PMID: 37891072 Clinical Trial.
59 results